Selecting an A1C Point-of-Care Instrument
Open Access
- 1 August 2015
- journal article
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 28 (3) , 201-208
Abstract
A1C point-of-care (POC) instruments benefit patients with diabetes by facilitating clinician decision making that results in significant glycemic improvements. Three National Glycohemoglobin Standardization Program (NGSP)–certified POC products are available in the United States: the handheld A1CNow (formerly manufactured by Bayer Diabetes Care but now made by Chek Diagnostics) and two bench-top models called the Axis-Shield Afinion Analyzer and the Siemens DCA Vantage. This article compares the three available NGSP-certified POC products in terms of accuracy, precision, ease of use, cost, and additional features. Its goal is to aid health care facilities in conveniently identifying the A1C POC product that best meets their needs. It additionally reviews evidence that supports the continued use of A1C POC instruments in the clinical arena.Keywords
This publication has 23 references indexed in Scilit:
- Accuracy and Clinical Utility of a Point-of-Care HbA1c, Testing DevicePostgraduate Medicine, 2013
- Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes MellitusClinical Chemistry, 2011
- Six of Eight Hemoglobin A1c Point-of-Care Instruments Do Not Meet the General Accepted Analytical Performance CriteriaClinical Chemistry, 2010
- Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes TrialsCirculation, 2009
- The Effect of Elevated Fetal Hemoglobin on Hemoglobin A1cResultsAmerican Journal of Clinical Pathology, 2008
- Desirable performance standards for HbA1c analysis – precision, accuracy and standardisation Consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA)Clinical Chemistry and Laboratory Medicine (CCLM), 2007
- Capital Equipment Investments in Diabetes CareClinical Diabetes, 2004
- Point-of-Care Testing: Millennium Technology for Critical CareLaboratory Medicine, 2000
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993